Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Beachler

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|July 18, 2022
Incidence of safety events after immune checkpoint inhibitor initiation for advanced-stage non-small-cell lung cancer: a real-world studyDaniel C Beachler, Francois Xavier Lamy, Francesca Kolitsopoulos, et al.
Pragmatic and Observational Research|February 12, 2025
Validation of Mortality Data Sources Compared to the National Death Index in the Healthcare Integrated Research DatabaseAziza Jamal-Allial, Todd Sponholtz, Shiva K Vojjala, et al.
Pharmacoepidemiology and Drug Safety|August 13, 2024
Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018Todd Sponholtz, Aziza Jamal-Allial, Shiva K Vojjala, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2018
An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) StudyDaniel C Beachler, Ligia A Pinto, Troy J Kemp, et al.
Journal of Ovarian Research|September 2, 2020
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancerDaniel C Beachler, Francois-Xavier Lamy, Leo Russo, et al.
Pharmacoepidemiology and Drug Safety|February 5, 2025
The Healthcare Integrated Research Database (HIRD) as a Real-World Data Source for Pharmacoepidemiologic ResearchJohn J Barron, Vincent J Willey, Brett T Doherty, et al.
BMC Cancer|January 26, 2021
Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort studyDaniel C Beachler, Cynthia de Luise, Aziza Jamal-Allial, et al.
Vaccine|November 19, 2018
Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured populationDaina Esposito, Lina Titievsky, Daniel C Beachler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2021
Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid ArthritisMonica E D'Arcy, Daniel C Beachler, Ruth M Pfeiffer, et al.
Sexually Transmitted Diseases|June 14, 2017
The Natural History of Oral Human Papillomavirus in Young Costa Rican WomenDaniel C Beachler, Krystle A Lang Kuhs, Linda Struijk, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|July 18, 2022
Incidence of safety events after immune checkpoint inhibitor initiation for advanced-stage non-small-cell lung cancer: a real-world studyDaniel C Beachler, Francois Xavier Lamy, Francesca Kolitsopoulos, et al.
Pragmatic and Observational Research|February 12, 2025
Validation of Mortality Data Sources Compared to the National Death Index in the Healthcare Integrated Research DatabaseAziza Jamal-Allial, Todd Sponholtz, Shiva K Vojjala, et al.
Pharmacoepidemiology and Drug Safety|August 13, 2024
Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018Todd Sponholtz, Aziza Jamal-Allial, Shiva K Vojjala, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2018
An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) StudyDaniel C Beachler, Ligia A Pinto, Troy J Kemp, et al.
Journal of Ovarian Research|September 2, 2020
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancerDaniel C Beachler, Francois-Xavier Lamy, Leo Russo, et al.
Pharmacoepidemiology and Drug Safety|February 5, 2025
The Healthcare Integrated Research Database (HIRD) as a Real-World Data Source for Pharmacoepidemiologic ResearchJohn J Barron, Vincent J Willey, Brett T Doherty, et al.
BMC Cancer|January 26, 2021
Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort studyDaniel C Beachler, Cynthia de Luise, Aziza Jamal-Allial, et al.
Vaccine|November 19, 2018
Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured populationDaina Esposito, Lina Titievsky, Daniel C Beachler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2021
Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid ArthritisMonica E D'Arcy, Daniel C Beachler, Ruth M Pfeiffer, et al.
Sexually Transmitted Diseases|June 14, 2017
The Natural History of Oral Human Papillomavirus in Young Costa Rican WomenDaniel C Beachler, Krystle A Lang Kuhs, Linda Struijk, et al.
Pageof 6